[1]
2026. PHARMACOGENETIC STRATIFICATION OF METHOTREXATE-INDUCED LIVER INJURY RISK IN RHEUMATOID ARTHRITIS PATIENTS. International Congress on Economics, Management and Business Studies. 1, 6 (Jun. 2026), 947–950.